Shi Guohui, Ni Linlin, Zhang Yang, Qu Zhizi, Kong Xiaoni, Zhou Honglei, Xu Yan
Medical School, Shandong Xiehe University, Jinan, China.
College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
Front Pharmacol. 2025 Jun 26;16:1593724. doi: 10.3389/fphar.2025.1593724. eCollection 2025.
: (Bruce) J.F.Gmel. (), commonly known as "kosso," is a prevalent phytomedicine addressing aliments across Ethiopia. Traditionally, it is used to treat fever, abdominal pain, respiratory illnesses, intestinal parasitic infections, wound healing, and cancer. Current research has revealed its anthelmintic, antimicrobial, antihyperglycemic, antidyslipidemic, antidiarrheal, and antioxidant activities. These pharmacological properties might be attributed to the presence of secondary metabolites, such as terpenoids, flavonoids, and phenols. Its crude extract is safe at doses less than 2,000 mg/kg, but larger doses can cause damage to the optic nerve. Although significant research findings are available, challenges remain. This paper provides a comprehensive review of research findings, identifying gaps in mechanistic studies and standardized toxicology assessments. Future priorities include applying ConPhyMP guidelines for extract characterization and integrating traditional knowledge with biodiversity conservation.
(布鲁斯)J.F.Gmel.(),通常被称为“科索”,是一种在埃塞俄比亚广泛使用的植物药,用于治疗多种疾病。传统上,它被用于治疗发烧、腹痛、呼吸道疾病、肠道寄生虫感染、伤口愈合和癌症。目前的研究揭示了它具有驱虫、抗菌、降血糖、抗血脂异常、止泻和抗氧化活性。这些药理特性可能归因于次生代谢产物的存在,如萜类化合物、黄酮类化合物和酚类。其粗提物在剂量小于2000毫克/千克时是安全的,但较大剂量会对视神经造成损害。尽管有大量的研究结果,但挑战依然存在。本文对研究结果进行了全面综述,找出了机制研究和标准化毒理学评估方面的差距。未来的重点包括应用ConPhyMP指南进行提取物表征,并将传统知识与生物多样性保护相结合。